Inflammatory bowel disease (IBD)
Effectiveness Research in Inflammatory Bowel Disease: A Necessity and a Methodological Challenge
... Efficacy, safety and economic issues are the main factors influencing the use of inflammatory bowel disease [IBD]-related medications. The best level of evidence comes from randomised clinical ...
8
Discrimination between inflammatory bowel disease (IBD) phenotypes by GC×GC-HRTOFMS
... DISCRIMINATION BETWEEN INFLAMMATORY BOWEL DISEASE (IBD) PHENOTYPES BY GC×GC-HRTOFMS Nicolas J. Di Giovanni 1 , M-A Meuwis 2 , E Louis 2 , J-F Focant 1 1 MS Laboratory Organic and Biological ...
1
Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail
... of Inflammatory Bowel Disease (IBD) has not yet been fully ...gut inflammatory process 2, 3, 4, 5, 6, 7 ...pro- inflammatory microorganisms and a decreased proportion of ...
20
Management of patients with inflammatory bowel disease and spondyloarthritis
... in Inflammatory Bowel Disease) consensus defined mucosal healing in combination with resolution of symptoms as one of the major treatment goals for patients with IBD 41 ...and ...
46
Ecological Structuring of Temperate Bacteriophages in the Inflammatory Bowel Disease-Affected Gut
... bacteriophage; inflammatory bowel disease; ulcerative colitis; Crohn’s disease; gut microbiota ...Introduction Inflammatory bowel disease (IBD) encompasses a group of ...
16
Common variants at five new loci associated with early-onset inflammatory bowel disease.
... early-onset inflammatory bowel disease Marcin Imielinski 1,28 , Robert N Baldassano 2,3,28 , Anne Griffiths 4,28 , Richard K Russell 5,28 , Vito Annese 6,28 , Maria Dubinsky 7,28 , Subra Kugathasan ...
13
Singular manifolds of proteomic drivers to model the evolution of inflammatory bowel disease status
... the inflammatory conditions of the colon and small intestine become chronic, then, they are all generally grouped under the heading of Inflammatory bowel disease ...intestinal disease ...
13
View of Inflammatory Bowel Disease: An interview with Dr. John Marshall
... past/current Inflammatory Bowel Disease research ...small bowel meal with pneumocolon, for investigation of terminal ileal Crohn’s disease ...detecting disease relative to a gold ...
4
Association mapping of inflammatory bowel disease loci to single variant resolution.
... 39. Roadmap Epigenomics Consortium et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015). Supplementary Information is available in the online version of the paper. Acknowledgements We ...
19
View of Management of Patients with Inflammatory Bowel Disease Hospitalized in Intensive Care Unit
... chronic inflammatory bowel disease (IBD) [Crohn ’s disease and ulcerative colitis] are more likely to be hospitalized in intensive care unit because of their immunosuppressive and/or biologic ...
8
Brain-gut interactions in inflammatory bowel disease.
... inactive disease (90-94). Regardless of disease type, individuals with increased disease activity were more likely to report increased anxiety and depression while individuals with decreased ...
53
Plasmacytoid Dendritic Cells Are Largely Dispensable for the Pathogenesis of Experimental Inflammatory Bowel Disease
... France Inflammatory bowel disease (IBD) is a chronic inflammatory condition caused by an aberrant immune response to microbial components of the gastrointestinal ...the disease remains ...
17
Review article: withdrawal of 5-aminosalicylates in inflammatory bowel disease.
... “inflammatory bowel disease”, “Ulcerative Colitis” and “Crohn's Disease” with the subheadings “5-ASA with- drawal”, “5-ASA de-escalation”, “risk of relapse”, “cost saving” and “colorectal ...
12
Strategic use of immunosuppressants and anti-TNF in inflammatory bowel disease.
... Edouard Louis Department of Gastroenterology, University Hospital CHU of Liège, Liège , Belgium ti-TNF? The main justification of immunosuppressant mono- therapy is the low cost of this treatment and the possibility of ...
6
Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel Disease.
... for inflammatory bowel ...Crohn’s disease and ulcerative colitis have demonstrated a risk of relapse, which varies between 20 and 50% at 1 year and between 50 and 80% beyond 5 ...
6
Upregulation of enteric alpha-synuclein as a possible link between inflammatory bowel disease and Parkinson's disease
... between inflammatory bowel disease and Parkinson’s disease Pascal Derkinderen ,1 Wendy Noble,2 Michel Neunlist,1 Malvyne Rolli-Derkinderen 1 , Inserm, TENS, The Enteric Nervous System in Gut ...
4
Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel disease
... 11. Salmon JF, Wright JP, Murray AD. Ocular inflammation in Crohn’s disease. Ophthalmology 1991;98:480–4. 12. Matsuo T, Yamaoka A. Retinal vasculitis revealed by fluorescein angiography in patients with ...
49
Preliminary approach for crypt detection in Inflammatory Bowel Disease
... in Inflammatory Bowel Disease Bassem Ben Cheikh 1,2,3, ∗ , Philippe Bertheau 4 , Daniel Racoceanu 1,2,3 1 Sorbonne Universit´es, UPMC Univ Paris 06, UMR 7371, U1146, ...
3
Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease
... 7 (a) Li, H.; Jin, Z., Li, X.; Wu, L.; Jin, J. Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel ...
77
[Immunopathogenesis of inflammatory bowel disease.]
... 6 Moehle C, Ackermann N, Langmann T, Aslanidis C, Kel A, Kel-Margoulis O, et al. Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. J Mol ...
13